[Remote] Head of Government Affairs, AMR at Illumina

Washington, District of Columbia, United States

Apply Now

Not SpecifiedCompensation

Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Genomic Technology, Biotechnology, HealthcareIndustries

Requirements

The Head of Government Affairs, AMR role requires a strong understanding of federal legislation and regulations impacting the organization. Candidates should be adept at identifying, monitoring, and influencing government policy to optimize the business environment and patient access to solutions. Experience in educating public policymakers, managing political contributions, and developing advocacy coalitions is essential. A proven ability to represent the company effectively through direct advocacy at federal and state levels is also required.

Responsibilities

This position involves overseeing the analysis of proposed federal legislation and regulations to determine their potential impact on the organization. The Head of Government Affairs will work with internal stakeholders to establish company positions on federal regulations and communicate these positions internally and externally. Key responsibilities include educating public policymakers, creating and maintaining a positive leadership image for Illumina, and collaborating with business units on government relations strategies. The role also entails managing major company events with government officials, serving as a key liaison, tracking legislative and regulatory activities, participating in industry associations, and building third-party ally advocacy efforts.

Skills

Government Affairs

Public Policy

Legislation Analysis

Stakeholder Management

Regulatory Affairs

Communication

Advocacy

Illumina

Supports genomics startups through funding and resources

About Illumina

Illumina focuses on fostering innovation in the genomics industry by supporting startups through its Illumina Accelerator program. This program helps entrepreneurs create, launch, and grow genomics-focused companies by providing funding and resources. The accelerator operates in two main locations: the San Francisco Bay Area and Cambridge, UK. Illumina Accelerator has successfully invested in 68 genomics startups, which have collectively raised over $1 billion in venture capital. What sets Illumina apart from its competitors is its strong partnership with leading venture capital investors and its dedicated focus on the genomics sector. The goal of Illumina is to build a thriving ecosystem for genomics innovation, enabling new companies to emerge and advance the field.

San Diego, CaliforniaHeadquarters

1998Year Founded

$27.2MTotal Funding

IPOCompany Stage

Venture Capital, BiotechnologyIndustries

5,001-10,000Employees

Risks

Over-reliance on NVIDIA's AI technology may limit flexibility in AI solution adoption.

Standardizing proteomics data across platforms could challenge Illumina's data reliability.

Single-flow-cell NovaSeq X System might cannibalize sales of higher-end models.

Differentiation

Illumina leads in genomic sequencing with advanced AI integration and multiomic data analysis.

The company offers innovative array-based solutions for DNA, RNA, and protein analysis.

Illumina's global expansion includes a new Global Capability Center in Bengaluru.

Upsides

Collaboration with NVIDIA enhances drug discovery and clinical development through AI integration.

Pilot proteomics program with UK Biobank aims to generate crucial reference datasets.

Single-cell sequencing kits make high-throughput sequencing accessible to smaller labs.

Land your dream remote job 3x faster with AI

Try Jobo Free